NEWS
Metcela Inc., a biotech startup specializing in fibroblast-based cell therapy, announces that the Japanese Patent Office (JPO) has issued Japanese Patent No. 6618066 to support the company’s technology of VCF (VCAM-1-positive Cardiac Fibroblast).
PRESS RELEASE
Metcela Inc., a biotech startup specializing in fibroblast-based cell therapy, announces that the company was selected for J-Startup 2019, a public-private joint initiative for supporting startup. Read more…
MEDIA
Nikkei Sangyo Shinbun wrote an article on Metcela on 1st January, 2019 (Japanese)
https://www.nikkei.com/article/DGXMZO39653900U9A100C1000000/
NEWS
Metcela participated in “Research Studio 2018 powered by SPARK”, an acceleration program organized by Tsukuba Clinical Research & Development Organization (T-CReDO), and won the grand prize in the final pitch.
MEDIA
ASCII HealthTech wrote an article about Metcela on 10th October, 2018 (Japanese)
PRESS RELEASE
PRESS RELEASE
NEWS
Nikkei Shinbun wrote an article on Metcela on 18th September 2017 (Japanese).
https://www.nikkei.com/article/DGKKZO21214120V10C17A9TJE000/